Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Articles en relation
Commentaires
Laissez un commentaire
Tous les champs sont requis
En reproduction maintenant
Cadena Deportiva Latinoamericana
Au suivant
- Noticiero
- Somos Jóvenes
- Boletín
Plus de visites
- Le Laos, un ami fidèle et constant dans la lutte de Cuba contre le blocus des États-Unis
- Des médias et des groupes de réflexion abordent au Brésil la coopération entre les pays du Sud Global
- Le Conseil mondial de la paix condamne l'agression américaine contre Cuba
- Tremblement de terre ressenti à Santiago de Cuba
- Les causes de la défaite
